The intense challenges dealing with the Well being sector on the European degree had been talked about Ilias MosialosBrian Abel-Smith Professor of Well being Coverage and Head of the Division of Public Well being at LSE, within the context of the first SFEE Summit organized by the Affiliation of Greek Pharmaceutical Enterprises (SFEE) with the central theme “Redefining Worth”.
Mr. Mosialos expressed in his evaluation that “the following pandemic it will likely be the issue of resistance to antimicrobials” because of the resistance of microbes but in addition as a result of we do not need sufficient antibiotic arsenal in Europe. For that reason, Mr. Mosialos emphasised that “extra partnerships are wanted in public-private sector”, but in addition “critical epidemiological surveillance on the world degree” with investments in world facilities that can monitor developments within the microbial households. He additionally talked about that extra funds will likely be wanted in order that we’ve a vaccine a lot sooner if there’s a new pandemic, he additionally emphasised that “public-private partnerships are the answer to the following pandemic, offered they serve the general public curiosity.
Referring to the use and the chances it brings Synthetic Intelligence within the discipline of Well being, Mr. Mosialos stated: “Synthetic intelligence has arrived. In Greece, a particular committee has been established for this problem, however a consultant from the Well being sector doesn’t take part on this committee, though 30% of the full information in TN comes from the Well being discipline”.
He additionally identified within the evaluation that “Greece might have a comparative benefit within the discipline of utilizing synthetic intelligence within the Well being sector and be on the forefront of investments”, as a result of it has a person insurance coverage fund (EOPYY) and a joint social establishment (EDIKA), which collects medical information from a lot of the inhabitants. As he identified, Greece additionally wants a nationwide biobank. In collaboration with a analysis middle that can course of this information, with non-public entities and functions for the well being of residents, this information could possibly be a worthwhile reservoir that would entice overseas funding, as a result of “corporations need have information”.
Mr. Mosialos additionally referred to the necessity for Greece to make use of the necessary a part of the medical employees that migrated overseas throughout the disaster, creating synergies with the scientists and analysis facilities overseas the place they’re employed. Relating to the main challenges within the Well being sector within the coming years, Mr. Mosialos referred to the elevated chance of co-morbidities or a number of ailments, not solely within the aged, however primarily within the working inhabitants. As he stated, “we should talk this to the political management”, including that “well being may be an necessary consider financial improvement. We should be cautious after we anticipate the event of co-morbidity at youthful ages with preventive drugs applications that have to be prolonged past most cancers to circumstances similar to kidney illness for instance.”
The local weather disaster, in addition to the immigration disaster, are additionally main challenges for well being, which is able to result in the event of enormous cities, with out correct well being planning. “The coexistence of many individuals in small areas and coexistence with animals creates explosive conditions,” warned Mr. Mosialos, including that “the possibilities of a brand new pandemic are rising.”
Mr. Mosialos famous, lastly, that there’s “political fatigue” in Europe concerning points associated to public well being safety after the pandemic. Nevertheless, in January 2025, the “joint scientific analysis of progressive therapies” begins in Europe, beginning with cancer-related merchandise. “Our nation needs to be on the forefront of this course of,” Mr. Mosialos confused, including that “the competent establishments should be upgraded when it comes to expertise, whereas on the identical time making use of the Greeks who’re over lear, in order that we’re not the poor relative and take part within the analysis course of itself”.
Olympios Papadimitriou, president of the Affiliation of Greek Pharmaceutical Enterprises (SFEE), then emphasised the necessity to assist innovation within the discipline of pharmaceutical coverage, asserting the opening of the first SFEE Summit.
“The popularity of innovation throughout decision-making is absent from the nation’s pharmaceutical coverage,” Mr. Papadimitriou emphasised, noting on the identical time that “we have to create an innovation-friendly atmosphere along with the state.” “There are various challenges forward of us”, he admitted then, and on the identical time he introduced the necessary function of the pharmaceutical sector within the Greek financial system. In line with him, SFEE’s 60 member corporations cowl 90% of the drug market and provide 108,000 jobs, producing 3.4% of the nationwide GDP yearly (6.2 billion euros).
“We proceed the analysis and improvement of recent and established medicines, in order that residents have higher and higher entry to medicines”, emphasised Mr. Papadimitriou. Referring to the goals of the first SFEE Summit, he defined that “an try by SFEE to search out its personal platform for institutional dialogue with the state and the competent our bodies to succeed in a consensus on the main priorities, similar to the event of innovation. Right now we are going to attempt to redefine the worth of the business,” he stated.